FREE NEWSLETTER: Econintersect sends a nightly newsletter highlighting news events of the day, and providing a summary of new articles posted on the website. Econintersect will not sell or pass your email address to others per our privacy policy. You can cancel this subscription at any time by selecting the unsubscribing link in the footer of each email.

posted on 07 February 2017

Preventative Medicine: The Argument For And Against

from The Conversation

-- this post authored by James Brown, Aston University and Opeolu Ojo, University of East London

Preventative medicine has long used drugs to prevent the onset of disease. Those with symptoms such as high blood sugar or pressure are often diagnosed with the “pre-condition", such as prediabetes or prehypertension, if their symptoms haven’t yet reached the levels which define the disease.

It is estimated that around 7m people in the UK alone have prediabetes and have an increased risk of developing type 2 diabetes. But diagnosis of this pre-condition allows pharmaceutical drugs to be prescribed, which could delay or prevent the onset of the disease. However, there are arguments which support and condemn pre-treatment in this way.

We asked two experts to explain.

Prevention is better than cure

Opeolu Ojo is a lecturer in Biochemistry at the University of East London.

A pre-condition shows that something is clearly wrong within the body and therefore medicalising a person with a pre-condition is reasonable. Prevention is better than cure, and an advantage of treating a pre-condition as a medical issue is that it emphasises the seriousness of the changes that are happening within the body.

In prediabetes for instance, the concentration of glucose in the blood is already higher than normal, and as with other preconditions, there are signs that point towards disease development. It is likely to become a problem in the future. It is also known that if no action is taken, every year around 10% of people with prediabetes will develop type 2 diabetes.

If prediabetes is treated, it encourages the person to take appropriate actions which can prevent the pre-condition from progressing into full-blown disease. If prediabetes is not tackled, we would certainly see a rise in type 2 diagnoses.

An issue with medicalisation in this way is that it increases the demand for drugs and therefore the cost of healthcare. But these costs are small compared to the treatment of full disease which may be prevented. Pre-condition diagnosis also allows for future predictions and planning. The International Diabetes Federation, for example, has predicted that around 642m people will suffer from diabetes by 2040 - this prediction allows for planning future public health programmes and treatment options.

Prescription of medicines is an easy method of disease prevention. Shutterstock

It is true that social and cultural factors, such as diet and exercise, may contribute to the development of several health conditions, and so labels such as “prediabetes" or “prehypertension" have been criticised as attempts to individualise the problem - to shift the blame onto the patient. But recognising the danger of disease development encourages positive changes in behaviour, and claims that these labels may lead to low self-esteem and negative body image have little evidence to support them.

Of course, medicalisation of pre-conditions should only be carried out when necessary. But to abolish this precautionary measure would have far-reaching consequences on our healthcare systems and people’s quality of life.

Medicines aren’t always the answer

James Brown is a lecturer in Biology and Biomedical Science at Aston University

At first glance, it makes perfect sense to prescribe preventative medicine if a person has a high risk of developing a chronic disease - especially one that is expensive to treat. This has been most apparent with type 2 diabetes, which is now at epidemic proportions in the UK and strong evidence does show that anti-diabetic drugs, such as metformin, can lower the risk of developing diabetes in high risk individuals. Prevention is indeed of vital importance, but even if drugs can delay diabetes, should we routinely prescribe them just to reduce diabetes diagnosis rates?

We routinely screen people to provide early diagnosis of diseases, but often these tests are flawed and can lead to the treatment of healthy individuals - a lot of money can be made from labelling healthy people as sick. It is, after all, in the commercial interest of pharmaceutical companies to increase their end users, and some are known to sponsor studies that define disease and promote their treatments. What better way to sell more drugs than to widen the boundaries of illness to include pre-conditions?

Continued controversy of this kind surrounds the use of statins. Despite numerous clinical trials, and decades of use, scientists and clinicians still cannot agree on whether the benefits outweigh the risks in statin users who have not yet had a heart attack. Yet, while this disagreement continues, drug companies make over £15 billion per year from statin sales alone.

Inappropriate medicalisation can also carry a number of dangers including unpleasant or dangerous side effects of medication, poor treatment decisions, and economic waste. Yet we risk this becoming a reality for numerous “pre-conditions" since they could benefit from the use of drugs.

Exercise and a healthy diet could be more beneficial. Shutterstock

We lose a battle when healthy people are labelled in this way and we lose focus on what the real problems are - the vast majority of cardiovascular disease worldwide is caused by smoking, physical inactivity and poor diet. But rather than focusing on these problems, we prescribe statins and other drugs, and opportunities to improve the overall health of these people are missed.

Type 2 diabetes also has well known risk factors, such as obesity, and the benefits of exercise and a healthy diet can often go beyond treating just one condition. We also could lower the risk of developing other diseases, such cancer or dementia, but when healthy people with unhealthy lifestyles are medically treated, the incentive to exercise and eat well is reduced. After all, they are already being treated.

Treating these conditions ultimately diverts money away from the treatment or prevention of diseases that simply cannot be prevented by lifestyle changes. And since the NHS is already at breaking point, the capacity needed for managing and tracking those with pre-conditions will add extra pressure .

Health care professionals should educate, as well as treat patients, and care should be provided based on a person’s clinical need - not medical, pharmaceutical or financial targets. It may seem logical to turn to our arsenal of medicines to prevent sickness, but the costs in the end are just too high.

The ConversationJames Brown, Lecturer in Biology and Biomedical Science, Aston University and Opeolu Ojo, Lecturer in Biochemistry, University of East London

This article was originally published on The Conversation. Read the original article.

>>>>> Scroll down to view and make comments <<<<<<

Click here for Historical News Post Listing

Make a Comment

Econintersect wants your comments, data and opinion on the articles posted. You can also comment using Facebook directly using he comment block below.

Econintersect Contributors


Print this page or create a PDF file of this page
Print Friendly and PDF

The growing use of ad blocking software is creating a shortfall in covering our fixed expenses. Please consider a donation to Econintersect to allow continuing output of quality and balanced financial and economic news and analysis.

Take a look at what is going on inside of
Main Home
Analysis Blog
Slow Economic Growth Will Be Around For A Long Time
The Job Guarantee, Wage-Price Inflation And Alternative Solutions: Part 2
News Blog
NASA Precise Landing Technologies Tested On Vertical Testbed Rocket
March 2017 Conference Board Consumer Confidence Highest Since 2000
Richmond Fed Manufacturing Survey Again Improves In March 2017.
Case-Shiller 20 City Home Price Index January 2017 Shows 5.7 % Year-over-Year Growth
A Changing Rulebook To Tame The New Global Arms Race
Infographic Of The Day: Chart: Understanding Alphabet's 4 Billion Dollar In "Other Bets"
Early Headlines: Asia Stocks And Dollar Up, Oil, Gold Steady, Obama Climate Policies Gone, US Oil Glut, Euro Surges, Shorts Remain, Trump Into Yemen?, Iran-Russia Deals, Cat 4 Cyclone Hits Oz, And More
March 27, 2017 Weather and Climate Report - Will the MJO Deliver a Nino?
The Most Reputable Companies Worldwide
Gut Bacteria Play A Role In Long-term Weight Gain
What We Read Today 27 March 2017 - Special Public Edition
Is Less More In The Smartphone Market
Average Gasoline Prices for Week Ending 27 March 2017 Statistically Unchanged - Again
Investing Blog
The Dollar's Coming Impact On Markets
The Real 401k Plan Manager 27 March 2017
Opinion Blog
Macron May Lead But Le Pen Remains The Big Story
Is The 20th Century Still The 'Hayek Century'?
Precious Metals Blog
These Gold Stocks Will Produce Much Bigger Gains Than Gold Itself
Live Markets
28Mar2017 Market Update: Wall Street Ends 8 Day Losing Streak, DOW Up Triple Digits After Strong Consumer Confidence Number, US Dollar Climbs Higher, Energy Up 1%
Amazon Books & More

.... and keep up with economic news using our dynamic economic newspapers with the largest international coverage on the internet
Asia / Pacific
Middle East / Africa
USA Government



Analysis Blog
News Blog
Investing Blog
Opinion Blog
Precious Metals Blog
Markets Blog
Video of the Day


Asia / Pacific
Middle East / Africa
USA Government

RSS Feeds / Social Media

Combined Econintersect Feed

Free Newsletter

Marketplace - Books & More

Economic Forecast

Content Contribution



  Top Economics Site Contributor TalkMarkets Contributor Finance Blogs Free PageRank Checker Active Search Results Google+

This Web Page by Steven Hansen ---- Copyright 2010 - 2017 Econintersect LLC - all rights reserved